Biological Effects of Quercetin in COPD Phase II

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2023
This study determines whether quercetin supplementation reduces the inflammation and oxidative stress markers in patients with chronic obstructive pulmonary disease. It is small study with 8 subjects receiving quercetin 1000 mg/day, 8 patients receiving 500 mg/day and 4 subjects receive placebo.
Epistemonikos ID: 72c31a1c5d1431d7fe5e445771a983339c2e9893
First added on: May 15, 2024